UPDATE: Goldman Sachs Upgrades Intuitive Surgical to Buy on Improving Fundamentals
Goldman Sachs upgraded Intuitive Surgical (NASDAQ: ISRG) from Neutral to Buy and raised the price target from $591.00 to $715.00.
Goldman Sachs commented, "ISRG shares have stalled out LTM (-100bp vs. SPX) as debate regarding future growth has intensified.
Tags:
UPDATE: Goldman Sachs Upgrades Intuitive Surgical to Buy on Improving Fundamentals,
Goldman Sachs Latest News